Petvivo Holdings Inc logo

Petvivo Holdings Inc (PETV)

Market Open
16 Jul, 19:25
NASDAQ (CM) NASDAQ (CM)
$
0. 77
+0.03
+3.577%
$
24.03M Market Cap
- P/E Ratio
- Div Yield
866 Volume
0 Eps
$ 0.74
Previous Close
Add Transaction
Day Range
0.7 0.77
Year Range
0.6 1.69
Want to track PETV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PETV trading today higher at $0.77, an increase of 3.577% from yesterday's close, completing a monthly decrease of -4.1913% or -$0.03. Over the past 12 months, PETV stock lost -32.7658%.
PETV is not paying dividends to its shareholders.
The last earnings report, released on Feb 12, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0745%, based on the last three reports.
Petvivo Holdings Inc has completed 2 stock splits, with the recent split occurring on Dec 30, 2020.
The company's stock is traded on one exchange.

PETV Chart

People also search for

ElectroCore, Inc.
$ 5.81
+0.519%
Atyr Pharma Inc.
$ 0.51
-1.7058%
Alterity Therapeutics Limited - Depositary Receipt (Common Stock)
$ 4.97
-2.2616%
Baird Medical Investment Holdings Inc.
$ 1.03
-1.9048%
FTH
Faeth Therapeutics, Inc.
$ 25.09
-3.2884%
PetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks Transcript

PetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks Transcript

PetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks Transcript

Seekingalpha | 2 weeks ago
PetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice Transcript

PetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice Transcript

PetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice Transcript

Seekingalpha | 1 month ago
PetVivo Holdings, Inc. (PETV) Q3 2026 Earnings Call Transcript

PetVivo Holdings, Inc. (PETV) Q3 2026 Earnings Call Transcript

PetVivo Holdings, Inc. (PETV) Q3 2026 Earnings Call Transcript

Seekingalpha | 4 months ago

Petvivo Holdings Inc (PETV) FAQ

What is the stock price today?

The current price is $0.77.

On which exchange is it traded?

Petvivo Holdings Inc is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is PETV.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 24.03M.

Has Petvivo Holdings Inc ever had a stock split?

Petvivo Holdings Inc had 2 splits and the recent split was on Dec 30, 2020.

Petvivo Holdings Inc Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
John Lai CEO
NASDAQ (CM) Exchange
716817408 CUSIP
US Country
20 Employees
- Last Dividend
30 Dec 2020 Last Split
23 May 2013 IPO Date

Overview

PetVivo Holdings, Inc. stands out as a dynamic biomedical device company dedicated to the design, manufacture, and marketing of medical devices and biomaterials aimed at treating conditions and diseases affecting animals. Founded in the year 2009 and with its headquarters situated in Minneapolis, Minnesota, the company has carved a niche for itself in the veterinary industry by focusing on the development and commercialization of innovative solutions for pets and livestock. Its activities span from the licensing of its groundbreaking technologies to the full-scale commercial production of its proprietary veterinary devices. Through its efforts, PetVivo aims to improve the quality of life for animals suffering from various afflictions, leveraging its expertise in the biomedical field to bring about positive changes in veterinary medicine.

Products and Services

PetVivo Holdings, Inc. has made significant strides in the veterinary medicine field with the introduction of various products, particularly focusing on the management of joint health and the enhancement of animal mobility. Key offerings include:

  • Spryng: This flagship product is an intraarticular injection designed to be administered by veterinarians for the treatment of lameness and other joint-related conditions, such as osteoarthritis in dogs and horses. Spryng serves as a notable example of PetVivo's commitment to improving animal health by providing an innovative, non-pharmaceutical intervention for joint diseases. Its aim is to enhance the quality of life for pets and livestock by alleviating pain and restoring mobility.
  • Pipeline Products: Beyond Spryng, PetVivo is actively working on a suite of therapeutic devices intended for both veterinary and human clinical applications. This expansion into a diverse range of products signifies the company’s dedication to broadening its impact within biomedical solutions, not just focusing on current needs but also anticipating future challenges in animal and potentially human health. Each product under development is a testament to PetVivo's innovative spirit and its endeavor to blend scientific research with practical healthcare solutions.

Contact Information

Address: 5251 Edina Industrial Boulevard
Phone: 952 405 6216